Best Selank 5 mg and 10mg Peptides GMP Factory

Selank

Selank

Other names:Selanc, L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-L-Proline, Cеланк, Na-selank, Na-selank-NH2, N-Acetyl Selank Amidate

Selank is a type of peptide and nootropic. Selank peptide has been shown to enhance cognitive function, reduce anxiety and stress, improve mood and sleep, and boost the immune response.One of the primary benefits of using selank peptide is its ability to reduce anxiety and stress levels. By stimulating GABA receptors, selank may promote relaxation and calmness while reducing tension and restlessness. Additionally, it helps regulate cortisol levels in the body, which are responsible for inducing stress responses. There are different form of Selank, include: Na-selank, Na-selank-NH2, N-Acetyl Selank Amidate.

Production capacity: Provide customization

Large Factory Professional Manufacturers & Factory

Production Carried OUT Under CGMP Regulation and Trackable

ISO9001 & ISO14000

Get a Bulk quotation

If you need a larger quantity. Please fill in the form, our BD (Business Development) will provide you with a competitive quotation.

Selank Peptide dosage calculator

Referenced Citations 

[1] Semenova TP, Kozlovskiĭ II, Zakharova NM, Kozlovskaia MM (2009). “[Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA]”. Eksperimental’naia i Klinicheskaia Farmakologiia. 72 (4): 6–8. PMID 19803361.

[2] Inozemtseva LS, Karpenko EA, Dolotov OV, Levitskaya NG, Kamensky AA, Andreeva LA, Grivennikov IA (2008). “Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo”. Doklady Biological Sciences. 421: 241–243. doi:10.1134/s0012496608040066PMID 18841804S2CID 40709909.

[3] Narkevich VB, Kudrin VS, Klodt PM, Pokrovskiĭ AA, Kozlovskaia MM, Maĭskiĭ AI, Raevskiĭ KS (2008). “[Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study]”. Eksperimental’naia i Klinicheskaia Farmakologiia. 71 (5): 8–12. PMID 19093364.

[4] “СЕМАКС: лекарственное средство широкого спектра действия эффективный стимулятор нервной системы” [SEMAX: a broad-spectrum drug effective stimulant of the nervous system]. Institute of Molecular Genetics (in Russian). Moscow. Archived from the original on 2011-07-22.

[5] Semenova TP, Kozlovskiĭ II, Zakharova NM, Kozlovskaia MM (August 2010). “[Experimental optimization of learning and memory processes by selank]”. Eksperimental’naia i Klinicheskaia Farmakologiia. 73 (8): 2–5. PMID 20919548.

[6] Kost NV, Sokolov OI, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA (2001). “Semax and selank inhibit the enkephalin-degrading enzymes from human serum”. Bioorganicheskaia Khimiia (in Russian). 27 (3): 180183. doi:10.1023/A:1011373002885PMID 11443939S2CID 26029820.

[7] Solov’ev VB, Gengin MT, Sollertinskaia TN, Latynova IV, Zhivaeva LV (2012). “[Effect of selank on the main carboxypeptidases in the rat nervous tissue]”. Zhurnal Evoliutsionnoi Biokhimii I Fiziologii (in Russian). 48 (3): 254–257. PMID 22827026.

[8] Sarkisova KI, Kozlovskiĭ II, Kozlovskaia MM (2008). “[Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice]”. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova (in Russian). 58 (2): 226–237. PMID 18661785.

[9] Uchakina ON, Uchakin PN, Miasoedov NF, Andreeva LA, Shcherbenko VE, Mezentseva MV, et al. (2008). “[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]”. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 108 (5): 71–75. PMID 18577961.

[10] Korneev EA, Kazakova TB (1999). “Current approaches to the analysis of the effects of stress on metabolic processes in cells of the nervous and immune systems”. Med. Immunology. 1 (1–2): 17–22.

[11] Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, et al. (October 2006). “Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus”. Brain Research. 1117 (1):5460. doi:10.1016/j.brainres.2006.07.108PMID 16996037S2CID 27592503.

[12] Eremin KO, Kudrin VS, Grivennikov IA, Miasoedov NF, Rayevsky KS (2004). Effects of Semax on dopaminergic and serotoninergic systems of the brain. Doklady Biological Sciences. 394 (1–6): 1–3. doi:10.1023/b:dobs.0000017114.24474.40PMID 15088389S2CID 12955434.

[13] Jump up to:a b Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS (December 2005). “Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents”. Neurochemical Research. 30 (12): 1493–1500. doi:10.1007/s11064-005-8826-8PMID 16362768S2CID 38202287.

[14] Pae CU (January 2008). “Therapeutic possibility of “Semax” for depression”. CNS Spectrums. 13 (1):2021. doi:10.1017/S1092852900016102PMID 18204410.

[15] Jump up to:a b c Bertolini A (March 2012). “Drug-induced activation of the nervous control of inflammation: a novel possibility for the treatment of hypoxic damage”. European Journal of Pharmacology. 679 (1–3): 1–8. doi:10.1016/j.ejphar.2012.01.004PMID 22293371.Syunyakov.Laboratory of Clinical Psychopharmacology, FSBI «Zakusov Institute of Pharmacology RAMS

Author of this article:

Dr. Jean Zeng graduated from king’s college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

T. Syunyakov

Laboratory of Clinical Psychopharmacology, FSBI «Zakusov Institute of Pharmacology RAMS»

T.N. Sollertinskaja

I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of RAS, Russia

M.V. Shorochov

I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of RAS, Russia

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. peptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.

Author of this article:

Dr. Jean Zeng graduated from king's college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

Stephen C. Bain
Diabetes Research Group, Swansea University Medical School, Swansea, SA2 8PP, UK
Department of Diabetes and Endocrinology, Singleton Hospital, Swansea Bay University Health Board, Swansea, SA2 8QA, UK

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Polypeptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.